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___________________________________________________________________23 
Abstract 24 
 25 
There is interest in determining levels of Mycobacterium avium subsp. 26 
paratuberculosis (MAP) contamination in milk. The optimal sample preparation for 27 
raw cows’ milk to ensure accurate enumeration of viable MAP by the peptide-28 
mediated magnetic separation (PMS)-phage assay was determined. Results 29 
indicated that milk samples should be refrigerated at 4 °C after collection and MAP 30 
testing should commence within 24 h, or samples can be frozen at -70 °C for up to 31 
one month without loss of MAP viability. Use of Bronopol is not advised as MAP 32 
viability is affected. The vast majority (> 95%) of MAP in raw milk sedimented to the 33 
pellet upon centrifugation at 2500 × g for 15 min, so this milk fraction should be 34 
tested. De-clumping of MAP cells was most effectively achieved by ultrasonication of 35 
the resuspended milk pellet on ice in a sonicator bath at 37 kHz for 4 min in ‘Pulse’ 36 
mode.   37 
___________________________________________________________________ 38 
 39 
  40 
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1.   Introduction 41 
 42 
Due to its possible association with various human conditions, such as 43 
Crohn’s disease and ulcerative colitis (Pierce, 2010) and Type 1 diabetes (Rosu et 44 
al., 2009), the presence of viable Mycobacterium avium subsp. paratuberculosis 45 
(MAP) cells in milk and dairy products is viewed as a potential food safety issue.  46 
MAP is the causative agent of Johne's disease, a contagious, chronic and 47 
sometimes fatal infection that primarily affects the small intestine of domestic 48 
ruminants such as cattle, sheep and goats (Stabel, 1998). Dairy cattle infected by 49 
MAP can shed live organisms in both milk and faeces, so potentially bulk milk could 50 
be contaminated either directly or indirectly by this bacterium. Whilst uncertainty 51 
remains about the public health/food safety significance of MAP, it would be prudent 52 
to monitor milk for presence of MAP to assess levels of contamination and hence 53 
potential for human exposure. The general desire is that our food should come from 54 
disease-free (including Johne’s disease-free) animals (Regulation (EC) No 55 
853/2004; European Parliament, 2004).   56 
 There is interest amongst dairy producers and processors to identify a rapid 57 
method that could be adopted to detect the presence of viable MAP in raw milk or 58 
dairy products. Whilst a number of conventional and quantitative PCR methods, able 59 
to detect and estimate numbers of MAP in milk have been developed in recent years 60 
(Timms, Gehringer, Mitchel, Daskalopoulos, & Neilan, 2011), the problem remains of 61 
differentiating whether a PCR positive result is due to DNA from viable or dead cells 62 
(Hanna, Connor, & Wang, 2005).  More recently, use of a phage-based test 63 
(FASTPlaqueTBTM assay, Biotec Laboratories Limited, Ipswich), as a quicker 64 
alternative to culture, for rapid detection of viable MAP was described (Stanley et al., 65 
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2007); its application to test naturally infected milk and milk products was 66 
subsequently reported (Botsaris, Liapi, Kakogiannis, Dodd, & Rees, 2013; Botsaris 67 
et al., 2010). This phage amplification method exploits the ability of a 68 
mycobacteriophage to replicate and amplify only within viable mycobacterial cells. 69 
The number of viable cells can be quickly estimated within 24-48 h based on the 70 
count of plaques (lysed areas) produced when infected cells burst in a lawn of 71 
Mycobacterium smegmatis (indicator) cells in an agar plate. We have previously 72 
optimised the original FASTPlaqueTBTM test conditions to maximise detection 73 
sensitivity and achieve accurate enumeration (Foddai, Elliott, & Grant, 2009). A 74 
magnetic separation step using paramagnetic beads coated with two MAP-specific 75 
peptide binders (aMp3 and aMptD; Stratmann, Dohmann, Heinzmann, & Gerlach, 76 
2006; Stratmann, Strommenger, Stevenson, & Gerlach, 2002) was introduced before 77 
the phage assay to add specificity for MAP (Foddai, Elliott, & Grant, 2010b), since 78 
the phage involved has a broader host range (Rybniker, Kramme, & Small, 2006). 79 
The peptide-mediated magnetic separation (PMS) both captures and concentrates 80 
MAP cells, separating them from non-target microorganisms and other possible 81 
inhibitors, thereby increasing the specificity and sensitivity of the subsequent phage 82 
assay.  83 
In light of the possibility of the PMS-phage assay being adopted by the dairy 84 
industry for milk testing, certain aspects of the milk testing protocol being applied at 85 
Queen’s University Belfast were investigated to ensure that milk sample storage and 86 
preparation before testing were optimal. The following were examined: a) effect of 87 
milk storage conditions prior to commencement of testing on the viability of MAP 88 
cells, and identification of the best milk storage conditions to be applied when 89 
immediate analysis of milk samples is not possible; b) the partitioning of MAP to milk 90 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
5 
 
pellet, cream and whey fractions after centrifugation, to identify which milk fraction 91 
should be tested to most accurately determine MAP contamination levels; and c) 92 
potential to introduce a de-clumping step before PMS to maximise accuracy of MAP 93 
counts obtained with the phage assay. The optimised phage assay was previously 94 
demonstrated to be a useful research tool for studies involving milk spiked with pure 95 
cultures of MAP (Foddai, Elliott, & Grant, 2010a), as it provides quantitative results 96 
for viable cells within 24 h. Therefore, the optimised phage assay was principally 97 
used throughout this study, although conventional culture on solid agar and qPCR 98 
were employed in some experiments to supplement or confirm phage assay results.  99 
 100 
2.   Materials and methods 101 
 102 
2.1.  Bacterial strains 103 
 104 
Four MAP strains, including two type strains (ATCC 19698 and NCTC 8578) 105 
and two milk isolates (796PSS and 806R; Grant, Ball, & Rowe, 2002), were grown in 106 
a shaker incubator for 4–6 weeks at 37 °C to statio nary phase in Middlebrook 7H9 107 
broth containing 10% OADC supplement (both from Difco) and 2 µg mL-1 mycobactin 108 
J (Synbiotics Europe SAS, Lyon, France). Cultures on solid agar for comparison of 109 
colony counts (cfu mL-1) with plaque counts (pfu mL-1) achieved by phage assay 110 
were obtained by spreading appropriate dilutions of Mycobacterium avium subsp. 111 
paratuberculosis onto Herrold’s egg yolk medium (comprised of 9 g bacteriological 112 
peptone, 4.5 g sodium chloride, 15.3 g bacteriological agar, 2.7 g beef extract, 4.1 g 113 
sodium pyruvate, 27 mL glycerol, 5 mL 2% malachite green, 100 mL sterile egg yolk, 114 
2 mg L-1 mycobactin J) and no antibiotics (HEYM). Agar plates were wrapped in 115 
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Duraseal laboratory sealing film (Diversified Biotech, MA, USA) and incubated at 37 116 
°C for 4–6 weeks before counting colonies.  Mycobacterium  smegmatis mc2 155, to 117 
be used as fast-growing sensor cells for the phage assay (see below) was cultured 118 
for 2–3 days at 37 °C to stationary phase in the sa me 7H9 medium without the 119 
addition of mycobactin J.  120 
 121 
2.2.  Optimised phage amplification assay  122 
 123 
The optimised phage assay was carried out as previously described by 124 
Foddai et al. (2009). Briefly, after a previous overnight incubation of samples at 37 125 
°C in 1 mL of 7H9 medium containing 2 m M CaCl2, 100 µL D29 mycobacteriophage 126 
(108 pfu mL-1) was added to samples before incubation at 37 °C f or 2 h during which, 127 
particularly post-PMS samples, were shaken periodically every 20–30 min to keep 128 
uniform resuspension of paramagnetic beads. Virucide (100 mM ferrous ammonium 129 
sulphate (FAS, Sigma), 100 µL) was then added, samples were mixed thoroughly by 130 
accurate inverting and rolling (10 min at room temperature) in order to inactivate all 131 
exogenous seed phage before addition of 5 mL 7H9 medium containing 2 mM CaCl2. 132 
The samples were returned to the incubator at 37 °C  for a further 90 min before 133 
being plated onto agar plates prepared with 1 mL Mycobacterium smegmatis mc2 134 
155 (108 cfu mL-1) and tempered 7H9 agar.  Plaques were counted the following day 135 
after incubation of plates at 37 °C overnight. 136 
 137 
2.3.  Peptide magnetic separation   138 
 139 
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PMS was performed on 1 mL of sample using 5 µL biotinylated-aMp3 peptide- 140 
and 5 µL biotinylated-aMptD peptide-coated MyOneTM Tosylactivated Dynabeads® 141 
(Life Technologies), prepared in-house as described previously (Foddai et al., 142 
2010b). Magnetic separation was carried out using the Dynal BeadRetriever (Life 143 
Technologies) as described previously (Foddai et al., 2010b). Magnetic capture was 144 
carried out for 30 min at room temperature under continuous mixing, followed by two 145 
washes in 1 mL Phosphate buffered saline (PBS) containing 0.05% Tween 20 (PBS-146 
T20, Sigma), and final resuspension of the beads in 1 mL 7H9 broth containing 10% 147 
OADC and 2 mM CaCl2. For experiments involving PMS of spiked raw milk samples, 148 
7H9 medium was also supplemented with NOA Antimicrobial Supplement (Product 149 
code 3A201N-300, Abtek Biological Ltd, Liverpool UK; final concentrations per mL-1 150 
of broth: Nystatin 50 IU, Oxacillin 2 µg, Aztreonam 30 µg).  NOA inhibited growth of 151 
any milk bacteria adhering to the paramagnetic beads after PMS without impacting 152 
viability of the MAP cells, or affecting subsequent phage assay. 153 
 154 
2.4.  Investigation of use of ultrasound sonication to achieve MAP de-clumping   155 
 156 
The ultrasonic cleaning unit employed in this set of experiments was the 157 
Ultrasonic PH 30 (Fisher Scientific Ltd), which has two ultrasonic frequencies (37 158 
kHz and 80 kHz) and three operation modes (Sweep, Pulse, Degas).  Initially, 2 mL 159 
aliquots of broth suspensions containing approximately 105–106 MAP pfu mL-1 were 160 
processed through different ultrasonication treatments applied at ambient 161 
temperature (20–21 °C), using the three operation m odes at 37 and 80 kHz, for 162 
increasing time periods (0 to 5 min). Conventional de-clumping method consisting of 163 
vortexing samples with five sterile 3 mm glass beads for 2 min, routinely used at 164 
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Queen’s University Belfast (Rowe, Grant, Dundee, & Ball, 2000) to disperse clumps 165 
of MAP cells, was included as the control treatment for each experiment. Once the 166 
most promising ultrasonication setting had been established, the effect of 167 
ultrasonication treatment of samples on ice (suggested by Schleig et al., 2005), 168 
rather than directly in water bath at ambient temperature, was also evaluated. The 169 
effect of each de-clumping treatment was evaluated by comparing pfu, or cfu, counts 170 
obtained before and after treatment.  171 
 To investigate the potential for MAP cells to reclump quickly in samples not 172 
immediately processed after ultrasonication, 2 mL broth and whole UHT milk 173 
suspensions of four MAP strains containing approximately 105–106 cells mL-1 were 174 
de-clumped by the optimised ultrasonication treatment (identified during course of 175 
experiments outlined above), and then incubated for 0 min, 15 min, 30 min, 1 h and 176 
overnight (approximately 18 h) in a shaker incubator (100 rpm) at 37 °C before being 177 
processed in duplicate through the phage assay. If pfu counts recorded after each 178 
incubation time decreased then this was taken as evidence of re-clumping. 179 
 180 
2.5.  Assessment of the fractionation of MAP cells in spiked milk samples upon 181 
centrifugation   182 
 183 
Raw bulk tank milk from herds without a previous history of Johne’s disease 184 
or ultra-high temperature (UHT) processed milk purchased from a local supermarket 185 
was used for these experiments.  Milk samples (10 mL raw and 50 mL UHT) were 186 
inoculated with broth suspensions of MAP to give an initial concentration of 187 
approximately 106 pfu mL-1. Samples were centrifuged for 15 min at 2,500 × g in an 188 
Eppendorf centrifuge (model 5702) at room temperature to separate three milk 189 
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fractions (cream, whey, pellet). After determining the weight of each milk fraction, 190 
samples were de-clumped by optimised ultrasonication and processed immediately 191 
through the PMS-phage assay. For the cream and pellet fractions, which had been 192 
resuspended in 1 mL PBS-T20, the number of MAP cells was calculated as pfu 193 
counts per entire fraction. For the whey fraction the number of cells was determined 194 
by processing 1 mL of whey through the PMS-phage assay and then correcting the 195 
pfu count to take into account the total volume of the original whey fraction. The 196 
experiment was carried out in duplicate for each bacterial strain considered. 197 
 Quantitative PCR targeting both IS900 and f57 specific target-genes of MAP, 198 
used either alone (direct qPCR) or combined with prior PMS (PMS-qPCR), was 199 
carried out in parallel with the PMS-phage assay to verify the results obtained. DNA 200 
for samples processed through direct qPCR was extracted from each milk fraction as 201 
described by Hanifian, Khani, Barzegari, and Shayegh (2013). For samples to be 202 
processed through qPCR after PMS, bead samples were resuspended in a final 203 
volume of 50 µL RNAse/DNAse free water and DNA was released from captured 204 
cells by heating samples at 95 °C for 25 min. A 2.5  µL aliquot of the supernatant, 205 
after centrifugation to sediment beads, was used for each qPCR reaction. 206 
Quantitative PCR targeting both IS900 and f57 was performed as described 207 
previously by Donaghy, Johnson, and Rowe (2010). An internal amplification control, 208 
labelled with VIC at the 5’-end (EXO IPC - Exogenous Internal Positive Control 209 
Reagent) purchased from Applied Biosystems was included for each qPCR reaction. 210 
Comparison of EXO-IPC CT values obtained in negative test control (NTC) wells and 211 
unknown samples was undertaken to assess the possible presence of PCR 212 
inhibitors in samples tested. Higher EXO IPC CT values in unknown samples relative 213 
to NTC wells were taken as indicative of PCR inhibition.  Each qPCR reaction was 214 
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performed in a final volume of 25 µL including: TaqMan Universal 2X PCR master 215 
mix (Applied Biosystems), EXO IPC 10× mix and EXO IPC 10× DNA (Applied 216 
Biosystems), 10 µM of each forward and reverse primer and  5 µM of specific probe 217 
(Donaghy et al., 2010), and 2.5 µL template DNA. A calibration curve with DNA 218 
released from known amount of MAP (10-105 pfu mL-1) suspended in 7H9 broth was 219 
included with each qPCR run to allow quantification of numbers detected. qPCR 220 
reactions were performed using an EcoTM Real-Time PCR system (Illumina, Inc) with 221 
the following thermal cycling conditions: stage 1: 50 °C for 2 min; stage 2: 95 °C for 222 
10 min and stage 3 (40 cycles): 95 °C for 15 s and 60 °C for 1 min. 223 
 224 
2.6.  Assessment of the effect of refrigeration, freezing, and use of preservative on 225 
numbers of viable MAP in milk   226 
 227 
Whole UHT milk samples spiked with moderate (~104 cfu 50 mL-1) and low 228 
levels (~102 cfu 50 mL-1) of the four strains were processed through the PMS-phage 229 
assay applied after centrifugation at 2,500 × g, resuspension of milk pellet fraction in 230 
1 mL PBS-T20 and de-clumping by optimised ultrasonication. Samples were divided 231 
between three storage categories: 1) fresh - samples processed immediately or after 232 
overnight at 4 °C; 2) frozen - samples tested after  1 week, 2 weeks and 1 month at -233 
70 °C; and 3) chemically preserved - milk samples t reated with a milk preservative [1 234 
mL of a solution containing 1% Bronopol (Sigma-Aldrich, UK) added to 50 mL spiked 235 
milk, (i.e., final concentration 10 mg 50 mL-1 milk)] and tested after 1 and 2 weeks 236 
storage at 4 °C. Duplicate milk samples were tested  for each strain under all 237 
experimental conditions. Counts (pfu 50 mL-1) were compared for each storage 238 
condition relative to the starting bacterial spiking level; a decrease in pfu count was 239 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
11 
 
considered to be an indication of loss of viability by a proportion of MAP cells 240 
present.  241 
 242 
2.7.  Statistical analysis of results   243 
 244 
The statistical significance of the increase or reduction in plaque (pfu) and 245 
colony (cfu) counts observed for each treatment applied to broth and milk samples 246 
inoculated with viable MAP was assessed by a paired t test (Instat 3; GraphPad, La 247 
Jolla, CA); differences with P < 0.05 were considered significant. Correlation 248 
between numbers of MAP detected through PMS-phage assay and qPCR was 249 
assessed using linear regression analysis (Microsoft Excel). 250 
 251 
3.  Results 252 
 253 
3.1.  Use of ultrasonication to disperse MAP clumps 254 
 255 
To determine the optimal ultrasonication treatment to disperse clumps of MAP 256 
cells various treatments were studied. Of the different sonication settings applied in a 257 
sonicator bath at room temperature, the greatest degree of de-clumping was 258 
consistently achieved in samples processed through ultrasonication using Pulse 259 
mode; mean log10 increase in pfu counts for MAP strains ATCC 19698 and NCTC 260 
8578 were 0.17±0.02 and 0.23±0.08 (P < 0.01), respectively (Fig. 1A). 261 
Corresponding increases observed for samples de-clumped by vortexing samples 262 
with glass beads were 0.35±0.06 and 0.44±0.04, respectively (P < 0.001). Generally 263 
similar trends in terms of effects of each de-clumping treatment were observed with 264 
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cfu counts on HEYM (Fig. 1B), although log10 increases tended not to be as large as 265 
observed with pfu mL-1 results. 266 
 Significantly greater de-clumping was achieved when ultrasonication was 267 
applied to samples on ice in the sonicator bath (P < 0.001), rather than directly in the 268 
water bath at ambient temperature (Fig. 2A).  This was the case for all strains with 269 
the exception of MAP strain 806R which showed considerable variability in counts 270 
(large error bar) when vortexed with glass beads. Mean log10 increase in pfu counts 271 
observed for two type strains (ATCC 19698 and NCTC 8578) and two milk isolates 272 
(796PSS and 806R) were 0.90±0.08, 0.87±0.14, 0.36±0.03 and 0.51±0.08, 273 
respectively, with overall mean of 0.66±0.08. The corresponding mean log10 increase 274 
in pfu counts observed for samples de-clumped by vortexing with glass beads was 275 
lower for each MAP strain (0.60±0.10, 0.44±0.04, 0.20±0.02 and 0.37±0.30, 276 
respectively, with overall mean log10 increase in pfu of 0.40±0.12, P<0.01). No 277 
significant increase in pfu counts was observed for samples subjected to extended 278 
incubation on ice for 5 or 10 min before the ultrasonication treatment (P > 0.05 in 279 
both cases). Generally, similar trends in terms of effects of each de-clumping 280 
treatment were observed with cfu counts on HEYM (Fig. 2B), although log10 281 
increases tended not to be as large as observed with pfu mL-1 results. 282 
 The possibility of MAP cells re-clumping quickly after sonication treatment 283 
was estimated by comparing counts recorded from samples enumerated at various 284 
times after de-clumping. Mean pfu counts recorded for spiked milk samples 285 
immediately after de-clumping and after each incubation time did not vary 286 
significantly (P = 0.96), suggesting that no re-clumping occurred (Fig. 3A). Similar 287 
results were obtained for MAP broth cultures processed through the phage assay 288 
started after 0 min, 15 min, 30 min and 1 h (P = 0.06, Fig. 3B). However, a significant 289 
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increase in pfu mL-1 counts (~ 2 log10) was consistently recorded for MAP broth 290 
cultures incubated overnight in 7H9-OADC-2 mM CaCl2 at 37 °C  before the phage 291 
assay commenced (Fig. 3B). This substantial increase in pfu mL-1 was not 292 
unexpected, as it is consistent with our previous finding (Foddai et al., 2009) that 293 
there is enhanced phage infection of MAP cells and increased pfu counts when they 294 
have been incubated overnight in the presence of 2 mM CaCl2.  295 
 296 
3.2.  Fractionation of MAP cells within milk upon centrifugation 297 
 298 
Upon centrifugation of 10 or 50 mL volumes of MAP spiked milk at 2500 × g 299 
for 15 min, the vast majority of the MAP cells in both raw and UHT homogenised milk 300 
were consistently recovered from the milk pellet. Mean log10 pfu observed from both 301 
homogenised and non-homogenised milk inoculated with various MAP strains was 302 
6.28±0.25 and 6.38±0.06, respectively, corresponding to approximately 303 
81.53±5.76% and 96.7±1.7%, respectively, of the initial inocula. The percentage of 304 
bacterial cells recovered from the milk whey fraction ranged from 11.4 to 25.6% 305 
(overall mean 18.4±5.8%) for UHT homogenised milk and 0.4 to 2.9% (mean 306 
1.6±0.21%) for raw milk. The percentage of MAP recovered from the cream was 307 
lower than expected, on the basis of previous studies, in both cases; overall mean 308 
observed was 1.6±0.21% for whole raw and 0.06±0.02% for UHT homogenised milk. 309 
No significant difference in fractionation between MAP strains employed to spike raw 310 
and UHT milk was observed (P > 0.05). 311 
Numbers of MAP in each milk fraction estimated via direct-qPCR were more 312 
variable than PMS-qPCR, but similar trends in numbers of MAP cells per fraction 313 
were generally observed. Lack of sensitivity was observed when qPCR was applied 314 
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alone on DNA extracted from each raw milk fraction after centrifugation; CT values 315 
obtained from EXO IPC assay from samples were generally higher than those 316 
obtained from negative test control (NTC) samples indicating the presence of PCR 317 
inhibitors. Numbers of MAP estimated through IS900 and f57 direct-qPCR were 318 
consistently lower (by 1–2 log10) than corresponding values achieved through PMS-319 
phage assay and PMS-qPCR (P < 0.05 and P < 0.01, respectively). Best correlation 320 
was observed between qPCR and phage assay results (r2 = 0.8568 for IS900 qPCR 321 
and r2 = 0.7631 for f57 qPCR) when PMS was applied before qPCR for both types of 322 
spiked milk samples (Fig. 4A,B).  No significant variance of EXO-IPC CT values for 323 
all post-PMS DNA samples relative to NTC wells was observed, indicating apparent 324 
absence of PCR inhibitors in these samples.  325 
 326 
3.3.  Effect of various milk storage conditions pre-testing on MAP viability 327 
 328 
The effect of refrigeration, freezing, and use of preservative on numbers of 329 
viable MAP in milk was evaluated. Counts (pfu) detected from samples processed 330 
immediately or after one overnight at 4 °C were sim ilar (P > 0.05, Fig. 5A,B), 331 
suggesting that milk analysis can be performed on fresh or overnight refrigerated 332 
milk samples without adverse effect on MAP counts. Minimal reduction in numbers of 333 
MAP detected (P > 0.05) was observed from samples refrigerated for 3 days before 334 
milk analysis. Mean log10 decrease in pfu counts for both moderate-spiked (Fig. 5A) 335 
and low-spiked (Fig. 5B) milk samples was 0.41±0.08 and 0.15±0.10, respectively. 336 
No adverse effect on pfu counts (P > 0.05) was also observed from milk samples 337 
previously frozen at -70 °C for 1 or 2 weeks and 1 month before testing. Log10 338 
decrease in pfu counts ranged from 0.29±0.23 to 0.52±0.20 log10 for moderate (Fig. 339 
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5A), and from 0.01±0.20 and 0.20±0.24 for low-spiked level (Fig. 5B), suggesting 340 
minimal impact of frozen storage at -70 °C on viabi lity of MAP cells.  In contrast, 341 
addition of Bronopol, as a milk preservative, in combination with refrigeration at 4 °C 342 
for 1 and 2 weeks was found to severely impact viability of MAP cells. In the case of 343 
one MAP strain (806R) viability was so adversely affected that no viable MAP were 344 
detected in low spiked milk when testing was preceded by refrigeration for 2 weeks 345 
in the presence of Bronopol (Fig. 5B).  Counts (pfu) observed for milk samples 346 
processed after 1 and 2 weeks were consistently 1-2 log10 lower than those 347 
observed from fresh samples (Fig. 5A,B). Mean log10 decrease in pfu counts 348 
observed in moderate and low-spiked milk samples was 1.96±0.38 and 1.04±0.20 349 
after 1 week (P < 0.01) and 2.25±0.56 and 1.70±0.40 after 2 weeks (P < 0.001), 350 
respectively.  351 
 352 
4.  Discussion 353 
 354 
 355 
The objective of this study was to develop an optimised protocol for sample 356 
processing and PMS-phage assay testing of raw milk samples to ensure rapid 357 
detection and accurate enumeration of viable MAP, so a number of aspects of the 358 
current milk testing protocol were investigated. The first part of the study focused on 359 
the development of a non-invasive de-clumping method to maximise accuracy of 360 
MAP cells obtained through PMS-phage assay. Due to the hydrophobic nature of its 361 
cell wall, MAP cells tend to aggregate in clumps, the presence of which in test milk 362 
samples can lead to underestimates of MAP numbers by a factor of 100-1000 cells 363 
(Klijn, Herrewegh, & de Jong, 2001; Pearce et al., 2001). Various de-clumping 364 
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options, including repeated syringing (Keswani & Frank, 1998; Sung & Collins, 365 
1998), vortexing with glass beads (Rowe et al., 2000), and sonication (Chiodini & 366 
Hermon-Taylor, 1993; Stabel, Steadham, & Bolin, 1997) have previously been 367 
applied in the preparation of MAP inocula by other researchers. The method 368 
routinely applied at Queen’s University Belfast involves vortexing the MAP culture 369 
with five sterile 3 mm glass beads for 2 min. However, the sterile glass beads would 370 
generally be added to 7H9 broth at the time of preparation, not at the point of de-371 
clumping, which would be the case in the context of milk testing.  Introduction of 372 
glass beads to each test milk sample would be laborious and may increase the risk 373 
of introducing exogenous MAP DNA to the milk sample, if this approach were to be 374 
taken. A similar situation would exist in the case of syringing, the use of which would 375 
also require extra costs for additional sterile consumables. For these reasons, only 376 
treatment of samples in sealed tubes in a sonicator bath would seem to be a realistic 377 
proposition. The impact of different sonicator bath power settings and treatment 378 
temperatures and times on the viability of MAP cells was evaluated. Amongst the 379 
different sonication settings involving low-frequency ultrasound treatment (37 and 380 
80kHz) at ambient temperature, no significant de-clumping was observed. A small 381 
increase in MAP numbers compared to vortexing with glass beads (control 382 
treatment) suggested a minimal effect on disruption of MAP clumps. With the 383 
possible exception of one of the MAP field strains (MAP 806R), ultrasonication at 384 
37kHz on ice achieved significantly greater de-clumping of MAP suspensions than 385 
the control method (vortexing with glass beads).  When grown in broth, 806R forms 386 
particularly large aggregates of cells and generally proves difficult to de-clump and 387 
achieve a visually uniform suspension; the large error bars for vortexing of MAP 388 
806R (Fig. 2A) is reflective of this situation.  Overall, no adverse effect of de-389 
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clumping by ultrasonication at 37 kHz in Pulse mode for 4 min on the viability of MAP 390 
cells was observed.   391 
Milk samples to be tested for MAP generally require initial centrifugation to 392 
reduce large volumes (20–50 mL) to a 1 mL test volume appropriate for PMS. The 393 
PMS-phage assay and qPCR results obtained during the present study indicate that 394 
the milk pellet is the location of maximal numbers of MAP after centrifugation of a 395 
milk sample at 2,500 × g for 15 min at ambient temperature. Mean percentage 396 
recovery of MAP in the pellet estimated based on pfu counts for spiked homogenised 397 
UHT milk and spiked raw milk were >80% and 95%, respectively. Considerably lower 398 
proportions of MAP cells were generally recovered from the whey (18.4% and 1.6% 399 
for spiked homogenised UHT and raw milk, respectively) and cream (0.06% and 400 
1.6% for spiked homogenised UHT and raw milk, respectively) fractions.  Thus, in 401 
the case of raw milk samples negligible numbers of MAP would be lost if the whey 402 
and cream fractions were discarded after centrifugation; the picture for homogenised 403 
milk seems to be rather different. Comparison of results achieved by the two 404 
detection methods showed a better correlation between phage assay and PMS-405 
qPCR results than direct qPCR results; some evidence of PCR inhibition was 406 
obtained for direct qPCR, but not for PMS-qPCR. PMS was, therefore, confirmed to 407 
be an effective method to achieve selective concentration of target cells plus removal 408 
of PCR inhibitors from test samples.  Two previous fractionation studies carried out 409 
on raw milk inoculated with MAP showed that the vast majority of the original 410 
inoculum sediment to the milk pellet after centrifugation (Grant, Ball, & Rowe, 1998; 411 
Van Brandt et al., 2010). Another study (Gao, Odumeru, Raymond, & Mutharia, 412 
2005) reported that MAP cells preferentially partitioned to the cream fraction upon 413 
centrifugation, leading to a recommendation that the pellet and cream fractions 414 
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should be combined for MAP testing of milk.  The centrifugation conditions adopted 415 
by Van Brandt et al. (2010; 974 × g for 36 min at 4 °C) and Gao et al. (2005; 3100 × 416 
g for 30 min, temperature not stated) differ from those used by Grant et al. (1998) 417 
and in the current study (2,500 × g for 15 min at room temperature). In particular, 418 
temperature of centrifugation, or temperature of milk at time of centrifugation, may 419 
have impacted the differing fractionation profiles observed.  When processing raw 420 
milks in our laboratory, we purposely allow milk samples to attain ambient 421 
temperature before starting to test and always centrifuge at ambient temperature 422 
(not at 4 °C) to ensure that sedimentation of MAP c ells to the pellet is maximised.  423 
Another important consideration for the establishment of an optimised milk 424 
testing protocol was to discover the best milk storage condition to be adopted for 425 
milk samples if milk analysis cannot start immediately upon delivery of samples. Raw 426 
milk samples for MAP testing are usually collected miles away from the testing 427 
laboratory, and refrigeration, use of milk preservatives, or freezing samples are some 428 
of the methods used to preserve milk samples after collection or upon delivery. As 429 
the phage assay exploits the ability of D29 mycobacteriophage to replicate only 430 
within viable mycobacterial cells, maintaining the viability of MAP cells in test 431 
samples is critical. To the best of our knowledge, no information is currently available 432 
in the literature on how storage conditions including refrigeration, freezing, and use 433 
of preservative affect viability of MAP cells in milk. Results of the present study 434 
indicate that processing milk on the same day as collection or after overnight storage 435 
at 4 °C are the ideal conditions to maximise detect ion and achieve accurate 436 
enumeration of viable MAP cells. If this is not possible, then freezing of milk samples 437 
at -70 °C for up to one month could be alternativel y applied with minimal impact on 438 
viable MAP counts. In contrast, the addition of milk preservative (Bronopol) to milk 439 
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samples which are then refrigerated for 1 or 2 weeks at 4 °C weeks should be 440 
avoided as these conditions significantly affected viability of MAP; this could lead to 441 
underestimation of the number of MAP cells originally present in milk samples, or 442 
false negative results if <102 MAP cells are present per 50 mL milk. Our findings are 443 
in general agreement with the literature available on the subject. Use of milk 444 
preservatives, particularly Bronopol, have already been reported to cause bacterial 445 
membrane damage affecting both Gram-negative (Escherichia coli and 446 
Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus) bacteria 447 
(Shepherd, Waigh, & Gilbert, 1988; Stretton & Manson, 1973). This might explain the 448 
reduction in bacterial count as observed in our study and in other milk surveys 449 
previously carried out (Amores et al., 2010; Pinnow et al., 2001). Freezing of milk 450 
samples at -80 °C without adverse effect on the via bility of bacterial cells has 451 
previously been also reported for other pathogenic bacteria, including coagulase-452 
negative staphylococci and Gram-negative bacilli (Sanchez et al., 2003). 453 
  454 
5.  Conclusions 455 
 456 
Milk samples should be refrigerated at 4 °C after c ollection and MAP testing 457 
should commence within 24 h, or, when this is not possible, samples can be frozen 458 
at -70 °C for up to one month without significant l oss of MAP viability.  The vast 459 
majority (>95%) of MAP in raw milk were found to sediment to the pellet fraction 460 
upon centrifugation at 2500 × g for 15 min, so this milk fraction should be tested. De-461 
clumping of MAP aggregates before PMS is most effectively achieved by 462 
ultrasonication of the resuspended milk pellet on ice in a sonicator bath at 37 kHz for 463 
4 min in ‘Pulse’ mode.  Our findings regarding optimal milk storage and preparation 464 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
20 
 
prior to MAP testing by the PMS-phage assay should theoretically be equally 465 
applicable to milk samples to be cultured; however the effect of chemical 466 
decontaminants on viability of MAP cells that had been previously frozen and thawed 467 
would be an additional consideration. 468 
 469 
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Figure legends 1 
 2 
Fig. 1.  Comparison of the de-clumping effects of vortexing with glass beads for 2 3 
min (Control) and three ultrasonication treatments (Pulse Mode at 37 kHz for 2, 3 or 4 
4 min). Middlebrook 7H9 broth cultures of various MAP strains containing 105–106 5 
pfu mL-1 were placed in a steel basket and processed in a sonicator bath at ambient 6 
temperature (20 °C). MAP was enumerated by (A) phag e assay (pfu mL-1) and (B) 7 
culture on HEYM (cfu mL-1).  The larger the increase in log10 pfu mL-1 observed, the 8 
greater the de-clumping effect of the treatment. For each MAP strain results are 9 
mean ± standard deviation of two experiments with duplicate samples per 10 
experiment. 11 
 12 
Fig. 2. De-clumping effects of ultrasonication (Pulse Mode at 37kHz for 4 min) on ice 13 
compared with vortexing with glass beads for 2 min (Control). Middlebrook 7H9 broth 14 
cultures of four MAP strains containing 105–106 pfu mL-1 were processed in a 15 
sonicator bath on ice.  MAP was enumerated by (A) phage assay (pfu mL-1) and (B) 16 
culture on HEYM (cfu mL-1). The larger the increase in log10 pfu or cfu mL-1 17 
observed, the greater the de-clumping effect of the treatment.  For each MAP strain 18 
results are mean ± standard deviation of two experiments with duplicate samples per 19 
experiment. Bars represent (left to right): vortexing with glass beads for 2 min 20 
(control, ), ultrasonication on ice at 37 kHz for 4 min (), incubation for 5 min on 21 
ice before ultrasonication on ice at 37 kHz for 4 min (), and incubation for 10 min 22 
on ice before ultrasonication on ice at 37 kHz for 4 min ().   23 
 24 
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Fig. 3.  Investigation of possible re-clumping of MAP cells in (A) spiked milk samples 25 
and (B) Middlebrook 7H9 broth cultures after ultrasonication treatment. Samples 26 
were processed through the phage amplification assay immediately after 27 
ultrasonication (0 min, ) and at increasing times (15 min, ; 30 min, ; 1 h, ; 28 
overnight at 37 °C, ) post-ultrasonication. No significant decrease in MAP count, 29 
which would have been indicative of re-clumping, was observed. For each MAP 30 
strain, log10 pfu mL-1 results are mean ± standard deviation of two experiments with 31 
duplicate samples per experiment. 32 
 33 
Fig. 4. Relationship between MAP counts obtained by PMS-phage assay and 34 
corresponding numbers of MAP estimated by (A) PMS-IS900 qPCR and (B) PMS-35 
f57 qPCR for cream (white), whey (grey) and pellet (black) fractions after 36 
centrifugation of 10 mL raw milk (circles) and 50 mL homogenised UHT milk 37 
(diamonds) originally spiked with approximately 106 pfu MAP mL-1. Each data point 38 
represents the mean of two samples. 39 
 40 
Fig.5. Impact of pre-testing storage conditions on numbers of viable MAP in milk 41 
samples spiked with 104 pfu 50 mL-1. Four different MAP strains were used for 42 
spiking experiments. Milk samples were processed through the PMS-phage assay 43 
immediately after spiking and after different pre-testing storage conditions: (A) 44 
refrigeration at 4 °C, with and without addition of  Bronopol preservative, and (B) 45 
freezing at -70 °C. For each MAP strain results are  mean ± standard deviation of two 46 
experiments with duplicate samples per experiment.  Bars represent (left to right):  47 
immediate testing (), 4 °C overnight ( ), 4 °C for 3 days ( ), 1 week at 4 °C plus 48 
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Bronopol (), 2 weeks at 4 °C plus Bronopol ( ), 1 week at -70 °C ( ), 2 weeks at -49 
70 °C ( ), and 1 month at -70 °C (   ). 50 
 51 
 52 
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